Geode Capital Management LLC decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 0.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 4,165,518 shares of the company's stock after selling 28,471 shares during the period. Geode Capital Management LLC owned approximately 2.45% of Option Care Health worth $96,661,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Option Care Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after purchasing an additional 75,313 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. State Street Corp grew its stake in Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock valued at $195,849,000 after acquiring an additional 83,395 shares during the period. Norges Bank bought a new stake in shares of Option Care Health in the fourth quarter worth about $60,219,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reissued a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Barrington Research upped their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $33.00.
View Our Latest Report on OPCH
Insider Buying and Selling
In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is currently owned by insiders.
Option Care Health Stock Performance
Shares of OPCH stock traded up $0.29 on Monday, reaching $31.84. The stock had a trading volume of 4,564,946 shares, compared to its average volume of 1,788,693. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm has a market capitalization of $5.23 billion, a price-to-earnings ratio of 26.76, a P/E/G ratio of 2.30 and a beta of 1.07. The firm's 50-day moving average is $33.24 and its two-hundred day moving average is $28.58. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
